New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

NCT02329080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Methotrexate
DRUG: Rituximab
DRUG: Cytarabine
DRUG: Thiotepa
DRUG: liposomial cytarabine
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Carmustine
RADIATION: whole brain radiotherapy

Sponsor

International Extranodal Lymphoma Study Group (IELSG)